Download Library

 
Download Library
Document Type
A Randomized Trial of Exemestane +/- Seribantumab (MM-121) in Postmenopausal Women With Locally Advanced or Metastatic ER/PR+ HER2- Breast Cancer: Final Analysis and Extended Subgroup Analysis
Nanoliposomal targeting of Ephrin receptor A2 (EphA2): Clinical translation
Activity of an EphA2-targeted docetaxel nanoliposome in pancreatic patient-derived models as monotherapy and in combination with gemcitabine
MM-310, a novel EphA2-targeted docetaxel nanoliposome
Design and engineering of TRAIL fusion proteins for cancer therapy
MM-151 elicits broad and unique inhibition of cells harboring EGFR extracellular domain mutations —results of multiscale experiments with genome-edited cell lines
A network biology screen reveals ligand-receptor pathway connections and resistance mechanisms to RTK-directed therapies in cancer cells
HER2-targeted PEGylated liposomal doxorubicin (MM-302) efficiently targets the HER2 intermediate cell population in vitro and in vivo
Istiratumab (MM-141), a bispecific antibody targeting IGF-1R and ErbB3, inhibits pro-survival signaling in vitro and potentiates the activity of standard of care chemotherapy in vivo in ovarian cancer models
View Presentation
FirstPrevious
2
NextLast
= add file to Briefcase

In this section, you will find several of Merrimack’s high-resolution images. All images here are copyrighted by Merrimack Pharmaceuticals, Inc., and are made available here for editorial use only. By downloading and/or using any of the Merrimack’s images, you acknowledge the rights of Merrimack’s images, and you agree to comply with the usage guidelines.

X

Accept | Decline